Retrospective Study of the Level of HER2-neu Gene Amplification as Predictive Factor of Response in Patients With HER2-positive Advanced Breast Cancer Treated With Trastuzumab Containing Regimens.
Observational Model: Cohort, Time Perspective: Retrospective
Association of tumor cytogenetic paremeters with TTP and OS.
Armando Santoro, MD
Istituto Clinico Humanitas
Italy: Ministry of Health